Literature DB >> 20557425

Biochemical and histopathological alterations in TAR DNA-binding protein-43 after acute ischemic stroke in rats.

Masato Kanazawa1, Akiyoshi Kakita, Hironaka Igarashi, Tetsuya Takahashi, Kunio Kawamura, Hitoshi Takahashi, Tsutomu Nakada, Masatoyo Nishizawa, Takayoshi Shimohata.   

Abstract

Nuclear factor TAR DNA-binding protein-43 (TDP-43) is considered to play roles in pathogenesis of human neurodegenerative diseases, so-called TDP-43 proteinopathy, via its proteolytic cleavage, abnormal phosphorylation, subcellular redistribution, and insolubilization generating TDP-43-positive neuronal intracellular inclusions. The purpose of this study was to elucidate biochemical and histopathological alternations in TDP-43 specific to acute ischemic stroke. Adult male rats were subjected to a 90-min middle cerebral artery occlusion. We examined the proteolytic cleavage, phosphorylation, subcellular localization, and solubility of TDP-43 by immunoblottings and histopathological examinations using the ischemic and sham-operated cortex. The level of full-length TDP-43 (43 kDa) decreased and that of the 25-kDa C-terminal fragment increased after acute ischemic stroke, which can be explained by proteolytic cleavage of TDP-43. Cytoplasmic redistribution and altered nuclear distribution of TDP-43 was observed after acute ischemic stroke, whereas abnormal phosphorylation and insolubilization of TDP-43 as well as formation of intracellular inclusions were not observed. Ischemic neurons with the cytoplasmic redistribution of TDP-43 expressed ubiquitin and activated caspase 3 and were terminal deoxynucleotidyl transferase-mediated uridine 5'-triphosphate-biotin nick end labeling-positive. In conclusion, biochemical and histopathological alterations in TDP-43 were identified in rats after acute ischemic stroke, although there was very less similarity between TDP-43 alterations observed in acute ischemic stroke and those observed in TDP-43 proteinopathy.
© 2010 The Authors. Journal Compilation © 2010 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20557425     DOI: 10.1111/j.1471-4159.2010.06860.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Phosphorylated TDP-43 localizes to chronic cerebral infarctions in human brains.

Authors:  Takahiko Umahara; Toshiki Uchihara; Kentaro Hirao; Soichiro Shimizu; Haruo Hanyu
Journal:  Histol Histopathol       Date:  2020-06-18       Impact factor: 2.303

2.  Proteomic Analysis of Mouse Cortex Postsynaptic Density following Neonatal Brain Hypoxia-Ischemia.

Authors:  Guo Shao; Yongqiang Wang; Shenheng Guan; Alma L Burlingame; Fuxin Lu; Renatta Knox; Donna M Ferriero; Xiangning Jiang
Journal:  Dev Neurosci       Date:  2017-03-18       Impact factor: 2.984

3.  Protein Profile and Morphological Alterations in Penumbra after Focal Photothrombotic Infarction in the Rat Cerebral Cortex.

Authors:  Anatoly Uzdensky; Svetlana Demyanenko; Grigory Fedorenko; Tayana Lapteva; Alexej Fedorenko
Journal:  Mol Neurobiol       Date:  2016-06-21       Impact factor: 5.590

4.  Acute and chronically increased immunoreactivity to phosphorylation-independent but not pathological TDP-43 after a single traumatic brain injury in humans.

Authors:  Victoria E Johnson; William Stewart; John Q Trojanowski; Douglas H Smith
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

5.  Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment.

Authors:  Masato Kanazawa; Hironaka Igarashi; Kunio Kawamura; Tetsuya Takahashi; Akiyoshi Kakita; Hitoshi Takahashi; Tsutomu Nakada; Masatoyo Nishizawa; Takayoshi Shimohata
Journal:  J Cereb Blood Flow Metab       Date:  2011-02-09       Impact factor: 6.200

6.  A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology.

Authors:  Takenari Yamashita; Takuto Hideyama; Kosuke Hachiga; Sayaka Teramoto; Jiro Takano; Nobuhisa Iwata; Takaomi C Saido; Shin Kwak
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

Review 7.  Molecular, functional, and pathological aspects of TDP-43 fragmentation.

Authors:  Deepak Chhangani; Alfonso Martín-Peña; Diego E Rincon-Limas
Journal:  iScience       Date:  2021-04-21

Review 8.  Progranulin and TDP-43: mechanistic links and future directions.

Authors:  Samir Kumar-Singh
Journal:  J Mol Neurosci       Date:  2011-08-24       Impact factor: 3.444

Review 9.  Disease animal models of TDP-43 proteinopathy and their pre-clinical applications.

Authors:  Yu-Chih Liu; Po-Min Chiang; Kuen-Jer Tsai
Journal:  Int J Mol Sci       Date:  2013-10-09       Impact factor: 5.923

10.  Predominance of spliceosomal complex formation over polyadenylation site selection in TDP-43 autoregulation.

Authors:  Sara Bembich; Jeremias S Herzog; Laura De Conti; Cristiana Stuani; S Eréndira Avendaño-Vázquez; Emanuele Buratti; Marco Baralle; Francisco E Baralle
Journal:  Nucleic Acids Res       Date:  2013-12-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.